Join the Head and Neck (HN) Disease Group for the second annual Head & Neck Cancer Scientific Retreat. Highlighting the diverse head and neck cancer research initiatives at the University of Cincinnati Cancer Center, this retreat will encompass basic, translational and clinical investigations. The program is designed to strengthen the collective understanding of disease biology, tumor-immune dynamics, therapeutic approaches and patient outcomes.

Sessions will feature updates from clinical trials and explore emerging mechanisms of therapy resistance and anti-tumor immune responses. Keynote speaker Natalie Silver, MD, MS, FACS, Director of Head & Neck Cancer Research at the Cleveland Clinic, will discuss how integrated analyses of tumor genetics, intratumoral microbiota and the tumor microenvironment are revealing new insights into immunotherapy response and shaping next-generation combination strategies for patients with head and neck cancer.

The retreat will provide a collaborative forum for researchers and clinicians to share ideas, build partnerships and accelerate progress. Industry and clinical sponsors will also be in attendance, creating opportunities to engage with leaders across clinical, diagnostic and pharmaceutical sectors.

Notice: This registration is intended for event attendees only. If you are a representative/employee of a pharmaceutical company that is interested in sponsoring and/or attending, you must contact Sydney Kavish.

Register Now